The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Randomized phase III trial of intravenous (IV) versus hepatic intra-arterial (HIA) fotemustine in patients with liver metastases from uveal melanoma: Final results of the EORTC 18021 study.
Serge Leyvraz
No relevant relationships to disclose
Stefan Suciu
No relevant relationships to disclose
Sophie Piperno-Neumann
No relevant relationships to disclose
Jean-Francois Baurain
No relevant relationships to disclose
Marcin Zdzienicki
No relevant relationships to disclose
Alessandro Testori
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline
Ernest Marshall
No relevant relationships to disclose
Max E. Scheulen
No relevant relationships to disclose
Thomas Jouary
Consultant or Advisory Role - Bristol-Myers Squibb; Roche
Honoraria - Bristol-Myers Squibb; Roche
Sylvie Negrier
Honoraria - Novartis; Pfizer
Jan Baptist Vermorken
No relevant relationships to disclose
Eckhart Kaempgen
No relevant relationships to disclose
Xavier Durando
No relevant relationships to disclose
Dirk Schadendorf
No relevant relationships to disclose
Ravichandra Karra Gurunath
No relevant relationships to disclose
Larissa Polders
No relevant relationships to disclose
Gaetan De Schaetzen
No relevant relationships to disclose
Simon Vanderschaeghe
No relevant relationships to disclose
Marie-Pierre Gauthier
No relevant relationships to disclose
Ulrich Keilholz
No relevant relationships to disclose